Product NDC: | 0066-0494 |
Proprietary Name: | Benzaclin |
Non Proprietary Name: | Clindamycin phosphate and benzoyl peroxide |
Active Ingredient(s): | 50; 10 mg/g; mg/g & nbsp; Clindamycin phosphate and benzoyl peroxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0066-0494 |
Labeler Name: | Dermik Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050756 |
Marketing Category: | NDA |
Start Marketing Date: | 20001221 |
Package NDC: | 0066-0494-25 |
Package Description: | 1 JAR in 1 CARTON (0066-0494-25) > 25 g in 1 JAR |
NDC Code | 0066-0494-25 |
Proprietary Name | Benzaclin |
Package Description | 1 JAR in 1 CARTON (0066-0494-25) > 25 g in 1 JAR |
Product NDC | 0066-0494 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin phosphate and benzoyl peroxide |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20001221 |
Marketing Category Name | NDA |
Labeler Name | Dermik Laboratories |
Substance Name | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
Strength Number | 50; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |